Clin2
NCT06517797Possibly a fitNot yet recruiting

S1B-509 for weight loss: a one-year study

Obesity

Part of Hormones & metabolism clinical trials.

This study tests a new medicine, S1B-509, to see if it helps people with obesity and related health problems lose weight and keep it off over a year. You will be randomly assigned to get S1B-509 or a placebo, and everyone gets lifestyle coaching.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
210 people
Ages
25 years to 70 years
Study type
Interventional

Who can take part

  • You must be an adult with obesity (body mass index, or BMI, of 30 or higher, or 27 or higher with a weight-related condition like diabetes, high blood pressure, or sleep apnea).
  • You must have a waistline measurement of at least 33.5 inches for men (85 cm) or 35.5 inches for women (90 cm).
  • You must have a high amount of belly fat, confirmed by a scan (visceral fat area of 100 cm² or more).
  • You must be willing to follow a lifestyle program (diet and exercise) and take the study medicine as directed for the full year.
  • You must not be pregnant, planning pregnancy, or breastfeeding, and you must use reliable birth control during the study and for 6 months after.
  • You must not have had weight-loss surgery, and you must not be taking certain weight-loss or diabetes medicines within 3 months before starting the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07754474Recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07757087Recruiting· Phase 1
Study on energy use after weight loss

This study tests a new medicine to see how it affects the body's energy use after losing weight. It compares the medicine to a low-calorie diet or a placebo (a pill with no active ingredient) in adults with obesity.

Aarhus N
NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.